Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
41.51
+0.38 (0.92%)
At close: Dec 20, 2024, 4:00 PM
41.50
-0.01 (-0.02%)
After-hours: Dec 20, 2024, 4:00 PM EST
Mirum Pharmaceuticals Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for MIRM stock have an average target of 57.58, with a low estimate of 38 and a high estimate of 68. The average target predicts an increase of 38.71% from the current stock price of 41.51.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 13, 2024.
Analyst Ratings
The average analyst rating for MIRM stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 8 | 8 | 8 | 8 | 8 | 7 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 13 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $66 | Strong Buy | Reiterates | $66 | +59.00% | Nov 13, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $65 → $68 | Strong Buy | Maintains | $65 → $68 | +63.82% | Nov 13, 2024 |
| Baird | Baird | Buy Maintains $44 → $50 | Buy | Maintains | $44 → $50 | +20.45% | Nov 13, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $47 → $49 | Buy | Maintains | $47 → $49 | +18.04% | Oct 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $66 | Strong Buy | Reiterates | $66 | +59.00% | Oct 11, 2024 |
Financial Forecast
Revenue This Year
339.47M
from 186.37M
Increased by 82.14%
Revenue Next Year
428.34M
from 339.47M
Increased by 26.18%
EPS This Year
-1.66
from -4.00
EPS Next Year
-0.77
from -1.66
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 351.8M | 518.1M | 734.6M | |||
| Avg | 339.5M | 428.3M | 536.1M | |||
| Low | 324.9M | 384.2M | 449.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 88.7% | 52.6% | 71.5% | |||
| Avg | 82.1% | 26.2% | 25.2% | |||
| Low | 74.3% | 13.2% | 5.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.55 | 0.72 | 4.33 | |||
| Avg | -1.66 | -0.77 | 0.90 | |||
| Low | -1.72 | -1.52 | -1.22 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.